Abstract LB-122: LY2835219, a selective inhibitor of CDK4 and CDK6, inhibits growth in preclinical models of human cancer.

出版年份 2014 全文链接

标题

作者

关键词

出版物

Volume 73, Issue 8 Supplement, Pages LB-122-LB-122

出版商

American Association for Cancer Research (AACR)

发表日期

2014-08-15

DOI

10.1158/1538-7445.am2013-lb-122

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started